Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide versus ondansetron for nausea and vomiting after minor head trauma
IRCT20170609034403N3Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of metoclopramide and ondansetron in Nausea and Vomiting (3 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: nausea and vomiting. Started Mar 2018; status: completed.
02
Drugs
metoclopramideondansetron
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on IRCT20170609034403N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170609034403N3.